 General Electric Co won approval from the Food and Drug Administration to offer its D breastimaging technology in the US the company said adding substantial new competition to the fastgrowing market dominated by Hologic Inc Threedimensional imagingalso known as tomosynthesiscombines Xrays taken from multiple angles to produce a more detailed picture than regular mammograms The technology costs more than regular mammography but finds more cancers with fewer false alarms studies have found and is rapidly replacing
  